跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72,479 条关于
“Fel d 1”
全部
72,479
临床试验
42,575
药物
8,721
机构
3,820
资讯
17,363
去年
Real-World Study Confirms Effectiveness of Cat Allergen Immunotherapy for Respiratory Allergies
去年
D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01
2个月前
India Selects First Biotech Startups Under ₹1 Trillion R&D Initiative as Transparency Concerns Linger
去年
PD-1 Inhibitor Label Restrictions May Impede Gastric Cancer R&D
去年
Phase 1/2 KEYMAKER-U02 Trial: Pembrolizumab Shows Manageable Safety Profile in Stage IIIB-D Melanoma
4个月前
GLP-1 Drugs Drive Pharma R&D Returns to 7% as Obesity Overtakes Oncology in Pipeline Value
4个月前
D&D Pharmatech Raises $165M as MASH Drug DD01 Approaches Key Phase 2 Readout
3个月前
Sixteen Years of Data Show Biopharma R&D Returns Rebound to 7%, But Recovery Remains Concentrated in GLP-1 Therapies
6个月前
D&D Pharmatech and First Bio Secure European Patent for Novel Brain Disease Drug NLY02
2个月前
MindRank Secures $52M Series B to Advance AI-Native Drug R&D Engine and Oral GLP-1 Agonist MDR-001 into Phase III
第 1 页,共 1737 页
上一页
下一页